Guindalini RSC, Viana DV, Kitajima JPFW, Rocha VM, López RVM, Zheng Y, Freitas É, Monteiro FPM, Valim A, Schlesinger D, Kok F, Olopade OI, Folgueira MAAK (2022) Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. Sci Rep 12(1):4190

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416

Article  PubMed  CAS  Google Scholar 

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329–1333

Article  PubMed  Google Scholar 

Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812–822

Article  PubMed  CAS  Google Scholar 

Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062

Article  PubMed  Google Scholar 

De Felice F, Marchetti C, Musella A, Palaia I, Perniola G, Musio D et al (2015) Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis. Ann Surg Oncol 22(9):2876–2880

Article  PubMed  Google Scholar 

Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633–1637

Article  PubMed  CAS  Google Scholar 

Herold N, Hellmich M, Lichtenheldt F, Ataseven B, Hillebrand V, Wappenschmidt B, et al. 2022 Satisfaction and Quality of Life of Healthy and Unilateral Diseased. Genes (Basel). 13(8).

Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AI, Collée M, Meijers-Heijboer HEJ et al (2019) Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 177(3):723–733

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL (2016) Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg 212(4):660–669

Article  PubMed  Google Scholar 

Alaofi RK, Nassif MO, Al-Hajeili MR (2018) Prophylactic mastectomy for the prevention of breast cancer: Review of the literature. Avicenna J Med 8(3):67–77

Article  PubMed  PubMed Central  Google Scholar 

Sun J, Chu F, Pan J, Zhang Y, Yao L, Chen J et al (2023) BRCA-CRisk: a contralateral breast cancer risk prediction model for BRCA carriers. J Clin Oncol 41(5):991–999

Article  PubMed  CAS  Google Scholar 

Metcalfe KA, Eisen A, Poll A, Candib A, McCready D, Cil T et al (2021) Frequency of contralateral prophylactic mastectomy in breast cancer patients with a negative BRCA1 and BRCA2 rapid genetic test result. Ann Surg Oncol 28(9):4967–4973

Article  PubMed  Google Scholar 

Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC; Karlan BY, Khan S, Klein C, Kohlmann W; CGC; Kurian AW, Laronga C, Litton JK, Mak JS; LCGC; Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC; Senter-Jamieson L; CGC; Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. 2021 Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 19(1): 77–102.

Conover, W. J. (1999), Practical Nonparametric Statistics. New York: John Wiley & Sons, 3rd ed.

Fleiss, J. L.; Levin, B. & Paik, M. C. (2003), Statistical Methods for Rates and Proportions. Hoboken, N.J: John Wiley & Sons, 3rd ed.

Hosmer DW, Lemeshow SL (1989) Applied Logistic Regression. John Wiley & Sons, New York

Google Scholar 

Siegel, S. & Castellan Jr., N. J. (2006), Estatística Não-Paramétrica para Ciências do Comportamento. Porto Alegre: Artmed, 2ª edição.

Tabachnick, B.G. & Fidell, L.S. (2001), Using Multivariate Statistics. Boston: Allyn and Bacon, 4th ed, pp 966.

de Freitas Ribeiro AA, Junior NMC, Dos Santos LL (2024) Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario. Eur J Med Res 29(1):187

Article  PubMed  PubMed Central  Google Scholar 

Metcalfe K, Huzarski T, Gronwald J, Kotsopoulos J, Kim R, Moller P, Pal T, Aeilts A, Eisen A, Karlan B, Bordeleau L, Tung N, Olopade O, Zakalik D, Singer CF, Foulkes W, Couch F, Neuhausen SL, Eng C, Sun P, Lubinski J, Narod SA 2024 Hereditary Breast Cancer Clinical Study Group. Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. Br J Cancer. 130(2): 269–274

Metcalfe KA, Retrouvey H, Kerrebijn I, Butler K, O’Neill AC, Cil T, Zhong T, Hofer SOP, McCready DR (2019) Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer. Cancer 125(22):3966–3973

Article  PubMed  Google Scholar 

Covelli AM, Baxter NN, Fitch MI, McCready DR, Wright FC (2015) “Taking control of cancer”: understanding women’s choice for mastectomy. Ann Surg Oncol 22(2):383–391

Article  PubMed  Google Scholar 

Yao K, Stewart AK, Winchester DJ, Winchester DP (2010) Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol 17(10):2554–2562

Article  PubMed  Google Scholar 

Katz SJ, Janz NK, Abrahamse P, Wallner LP, Hawley ST, An LC, Ward KC, Hamilton AS, Morrow M, Jagsi R (2017) Patient reactions to surgeon recommendations about contralateral prophylactic mastectomy for treatment of breast cancer. JAMA Surg 152(7):658–664

Article  PubMed  PubMed Central  Google Scholar 

Makhnoon S, Levin B, Ensinger M, Mattie K, Volk RJ, Zhao Z, Mendoza T, Shete S, Samiian L, Grana G, Grainger A, Arun B, Shirts BH, Peterson SK (2023) A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes. Cancer Med 12(3):2875–2884

Article  PubMed  CAS  Google Scholar 

Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA. 2019 Hereditary Breast Cancer Clinical Study Group. International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. Br J Cancer. 121(1): 15–21